528 related articles for article (PubMed ID: 25637346)
1. The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis.
Liao KP; Playford MP; Frits M; Coblyn JS; Iannaccone C; Weinblatt ME; Shadick NS; Mehta NN
J Am Heart Assoc; 2015 Jan; 4(2):. PubMed ID: 25637346
[TBL] [Abstract][Full Text] [Related]
2. [Association between systemic inflammation and autoimmunity parameters and plasma lipid in patients with rheumatoid arthritis].
Xue C; Liu WL; Sun YH; Ding RJ; Hu DY
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):941-5. PubMed ID: 22321280
[TBL] [Abstract][Full Text] [Related]
3. Plasma kinetics of an LDL-like non-protein nanoemulsion and transfer of lipids to high-density lipoprotein (HDL) in patients with rheumatoid arthritis.
Pozzi FS; Maranhão RC; Guedes LK; Borba EF; Laurindo IM; Bonfa E; Vinagre CG
J Clin Lipidol; 2015; 9(1):72-80. PubMed ID: 25670363
[TBL] [Abstract][Full Text] [Related]
4. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
[TBL] [Abstract][Full Text] [Related]
5. Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study.
Park YB; Choi HK; Kim MY; Lee WK; Song J; Kim DK; Lee SK
Am J Med; 2002 Aug; 113(3):188-93. PubMed ID: 12208376
[TBL] [Abstract][Full Text] [Related]
6. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
Robinson JG; Ballantyne CM; Hsueh W; Rosen J; Lin J; Shah A; Lowe RS; Hanson ME; Tershakovec AM
J Clin Lipidol; 2011; 5(6):474-82. PubMed ID: 22108151
[TBL] [Abstract][Full Text] [Related]
7. Conventional lipid profile and lipoprotein(a) concentrations in treated patients with rheumatoid arthritis.
García-Gómez C; Nolla JM; Valverde J; Gómez-Gerique JA; Castro MJ; Pintó X
J Rheumatol; 2009 Jul; 36(7):1365-70. PubMed ID: 19369465
[TBL] [Abstract][Full Text] [Related]
8. Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis.
Peters MJ; Vis M; van Halm VP; Wolbink GJ; Voskuyl AE; Lems WF; Dijkmans BA; Twisk JW; de Koning MH; van de Stadt RJ; Nurmohamed MT
Ann Rheum Dis; 2007 Jul; 66(7):958-61. PubMed ID: 17314120
[TBL] [Abstract][Full Text] [Related]
9. Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis.
van Halm VP; Nielen MM; Nurmohamed MT; van Schaardenburg D; Reesink HW; Voskuyl AE; Twisk JW; van de Stadt RJ; de Koning MH; Habibuw MR; van der Horst-Bruinsma IE; Dijkmans BA
Ann Rheum Dis; 2007 Feb; 66(2):184-8. PubMed ID: 16760255
[TBL] [Abstract][Full Text] [Related]
10. Serum lipid pattern and apolipoproteins (A1 and B100) in active rheumatoid arthritis.
Magarò M; Altomonte L; Zoli A; Mirone L; Ruffini MP
Z Rheumatol; 1991; 50(3):168-70. PubMed ID: 1927062
[TBL] [Abstract][Full Text] [Related]
11. [Relation between paraoxonase activity, other HDL components and inflammatory state in hemodialyzed patients].
González AI; Brites F; Elbert A; Gómez-Rosso L; Berg G; Wikinski R; Schreier L
Medicina (B Aires); 2010; 70(6):508-12. PubMed ID: 21163737
[TBL] [Abstract][Full Text] [Related]
12. Effects of Baricitinib on Lipid, Apolipoprotein, and Lipoprotein Particle Profiles in a Phase IIb Study of Patients With Active Rheumatoid Arthritis.
Kremer JM; Genovese MC; Keystone E; Taylor PC; Zuckerman SH; Ruotolo G; Schlichting DE; Crotzer VL; Nantz E; Beattie SD; Macias WL
Arthritis Rheumatol; 2017 May; 69(5):943-952. PubMed ID: 28029752
[TBL] [Abstract][Full Text] [Related]
13. Association of Triple Therapy With Improvement in Cholesterol Profiles Over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial.
Charles-Schoeman C; Wang X; Lee YY; Shahbazian A; Navarro-Millán I; Yang S; Chen L; Cofield SS; Moreland LW; O'Dell J; Bathon JM; Paulus H; Bridges SL; Curtis JR
Arthritis Rheumatol; 2016 Mar; 68(3):577-86. PubMed ID: 26606398
[TBL] [Abstract][Full Text] [Related]
14. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
15. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
16. Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients.
Morris SJ; Wasko MC; Antohe JL; Sartorius JA; Kirchner HL; Dancea S; Bili A
Arthritis Care Res (Hoboken); 2011 Apr; 63(4):530-4. PubMed ID: 21452265
[TBL] [Abstract][Full Text] [Related]
17. Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapy.
Dahlqvist SR; Engstrand S; Berglin E; Johnson O
Scand J Rheumatol; 2006; 35(2):107-11. PubMed ID: 16641043
[TBL] [Abstract][Full Text] [Related]
18. Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles.
Yoo WH
J Rheumatol; 2004 Sep; 31(9):1746-53. PubMed ID: 15338494
[TBL] [Abstract][Full Text] [Related]
19. Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration.
Navarro-Millán I; Yang S; DuVall SL; Chen L; Baddley J; Cannon GW; Delzell ES; Zhang J; Safford MM; Patkar NM; Mikuls TR; Singh JA; Curtis JR
Ann Rheum Dis; 2016 Feb; 75(2):341-7. PubMed ID: 25609412
[TBL] [Abstract][Full Text] [Related]
20. Effect of Drug Therapy on Net Cholesterol Efflux Capacity of High-Density Lipoprotein-Enriched Serum in Rheumatoid Arthritis.
Ormseth MJ; Yancey PG; Solus JF; Bridges SL; Curtis JR; Linton MF; Fazio S; Davies SS; Roberts LJ; Vickers KC; Kon V; Michael Stein C;
Arthritis Rheumatol; 2016 Sep; 68(9):2099-105. PubMed ID: 26991245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
